Gloshell
Ingredients

Ingredient Dictionary

STEAROXYPROPYL DIMETHYLAMINE

Molecular structure

Definition

US FDA substance register · UNII 0VZ9S47W35 · registered name STEAROXYPROPYL DIMETHYLAMINE · single chemical substance

Source: US FDA Unique Ingredient Identifier (UNII)

Cosmetic roles

Softens hairHAIR CONDITIONING

Safety & regulatory references

Other restriction: ban substances that deplete the ozone layer

Source: EU CosIng ingredient list

More data — names, identifiers, properties, test records, literature

Official labels & definitions

JCIA labelling name ステアロキシプロピルジメチルアミン: 本品は、次の化学式で表される3級アミンである。

Source: JCIA labelling names (Japan)

Names & identifiers

STEAROXYPROPYL DIMETHYLAMINEINCI스테아록시프로필다이메틸아민Korean label name (MFDS standard)1-Propanamine, N,N-dimethyl-3-(octadecyloxy)-SynonymステアロキシプロピルジメチルアミンJapanese labelling name
CAS No.chemical registry number
17517-01-0
EC No.EU chemical inventory number
241-516-8
DTXSIDUS EPA chemical ID
DTXSID40169948
DTXCIDUS EPA compound ID
DTXCID2092439
IUPAC
N,N-Dimethyl-3-(octadecyloxy)propan-1-amine
Molecular formula
C23H49NO
Molecular weight
355.651 g/mol

What products actually use it for

What the 3 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

  • Softener and conditioner3

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

5 skin studies and 1 eye studies are on record.

Classed as low1

The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 6 studies
  • SkinIrr2
    Skin Irritation · QSAR Predicted
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
  • SkinSens1
    Skin Sensitization · QSAR Predicted
  • Ambiguous
    skin irritation: in vivo · Screening · other guideline: Q and A for application for quasi-drugs and cosmetics by Ministry of health, labour and welfare in Japan (Q14) The test protocol followed the recommended procedure of the application for quasi-drugs in Japan. according to
  • Skin irritation - category 2
    Skin Irritation · Screening
  • Eye irritation - category 2
    Eye Irritation · Screening

Source: US EPA CompTox dashboard

Linked databases 13